Plasma GFAP

There are 5 papers on plasma GFAP in aging research: 1 trial and 3 observational studies in people, 1 review.

Biomarker

5 papers study it80 more mention it9 findings

3 new papers in 30 daysSee all 85 papers on plasma GFAP

“higher plasma GFAP levels were significantly associated with increased odds of poor sleep (OR=1.67, 95% CI[1.03, 2.70], p = .036)”
Rest Interrupted: Plasma GFAP, Cerebral Microbleeds, and Sleep Disturbances in Neurodegeneration – Insights from the Southeast Asian BIOCIS StudyAAIC 2025 abstract2025doi:10.1002/alz70857_102597
  • Human trial1
  • Humans3

Interventions

1

Okinawa-based Nordic diet

downin humans1

1 study
  1. Okinawa-based Nordic diet decreases plasma GFAP in humans (type 2 diabetes).

    Human trialtype 2 diabetes3 monthsn = 30

More on Okinawa-based Nordic diet

Associations

8

Sleep latency

upin humans1OR 1.18

1 study
  1. Plasma GFAP is associated with sleep latency in humans (cognitively unimpaired) (OR=1.18, 95% CI[1.07, 1.30], p = .001).

    Humanscognitively unimpairedplasman = 1,801

Poor sleep

upin humans1OR 1.67

1 study
  1. Plasma GFAP is associated with poor sleep in humans (cognitively unimpaired) (OR=1.67, 95% CI[1.03, 2.70], p = .036).

    Humanscognitively unimpairedplasman = 1,801

Islet amyloid polypeptide

upin humans1

1 study
  1. Plasma GFAP is associated with islet amyloid polypeptide in humans (type 2 diabetes; baseline; adjusted for age, sex, and body mass index) (r = 0.478).

    Humanstype 2 diabetes; baseline; adjusted for age, sex, and body mass indexn = 30

More on Islet amyloid polypeptide

Proinflammatory plasma cytokines

upin humans1

1 study
  1. Plasma GFAP is associated with proinflammatory plasma cytokines in humans (type 2 diabetes; baseline; adjusted for age, sex, and body mass index) (r = 0.440 to r = 0.530).

    Humanstype 2 diabetes; baseline; adjusted for age, sex, and body mass indexn = 30

More on Proinflammatory plasma cytokines

Neurofilament light polypeptide

upin humans1

1 study
  1. Plasma GFAP is associated with neurofilament light polypeptide in humans (type 2 diabetes; baseline) (r = 0.400).

    Humanstype 2 diabetes; baselinen = 30

More on Neurofilament light polypeptide

Cognitive impairment

upin humans1

1 study
  1. Plasma GFAP is associated with cognitive impairment in humans (Autosomal dominant Alzheimer's disease).

    HumansAutosomal dominant Alzheimer's disease

Neurodegeneration

upin humans1

1 study
  1. Plasma GFAP is associated with neurodegeneration in humans (Autosomal dominant Alzheimer's disease).

    HumansAutosomal dominant Alzheimer's disease

Amyloid-beta load

upin humans1

1 study
  1. Plasma GFAP is associated with amyloid-beta load in humans.

    HumansAutosomal dominant Alzheimer's disease; stronger association in asymptomatic than symptomatic participants

More on Amyloid-beta load

Funding

1 grant since 2023

Alzheimer's Association

Latest

Dec 2025: 13Jan 2026: 8Feb 2026: 3Mar 2026: 5Apr 2026: 2May 2026: 3Jun 2026: 2Jul 2026: 2Aug 2026: 6Sep 2026: 0Oct 2026: 2Nov 2026: 147 papers in 12 months

See all 85 papers on plasma GFAP